These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31606473)

  • 1. Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial.
    Sebastianelli A; Spatafora P; Frizzi J; Saleh O; De Nunzio C; Tubaro A; Vignozzi L; Maggi M; Serni S; McVary KT; Kaplan SA; Gravas S; Chapple C; Gacci M
    Eur Urol Focus; 2021 Mar; 7(2):432-439. PubMed ID: 31606473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial.
    Sebastianelli A; Spatafora P; Frizzi J; Saleh O; Sessa M; De Nunzio C; Tubaro A; Vignozzi L; Maggi M; Serni S; McVary KT; Kaplan SA; Gravas S; Chapple C; Gacci M
    J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31362410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
    Kim SW; Park NC; Lee SW; Yang DY; Park JK; Moon DG; Yang SK; Lee SW; Moon KH; Ahn TY; Kim SW; Park K; Min KS; Ryu JK; Son H; Jung J; Hyun JS
    J Sex Med; 2017 Aug; 14(8):1018-1027. PubMed ID: 28760246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tadalafil vs tamsulosin in lower urinary tract symptoms (LUTS) as a result of benign prostate hyperplasia (BPH)-open label randomised controlled study.
    Singh I; Tk A; Gupta S
    Int J Clin Pract; 2020 Aug; 74(8):e13530. PubMed ID: 32542854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.
    Oelke M; Giuliano F; Mirone V; Xu L; Cox D; Viktrup L
    Eur Urol; 2012 May; 61(5):917-25. PubMed ID: 22297243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Singh DV; Mete UK; Mandal AK; Singh SK
    J Sex Med; 2014 Jan; 11(1):187-96. PubMed ID: 24165272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating Lower Urinary Tract Symptoms Caused by Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Meta-Analysis.
    Liu J; Zhou W; Zhang P; Zhang W; Chang C; Fu G
    Urol Int; 2024; 108(2):89-99. PubMed ID: 38081154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of tadalafil on lower urinary tract symptoms with erectile dysfunction].
    Ye XT; Huang H; Huang WP; Zhang FY
    Zhonghua Nan Ke Xue; 2019 Jun; 25(6):514-521. PubMed ID: 32223086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study.
    Negoro H; Goto T; Akamatsu S; Terada N; Kobayashi T; Matsui Y; Yamamoto T; Omura T; Yonezawa A; Matsubara K; Ogawa O
    Neurourol Urodyn; 2020 Jan; 39(1):237-242. PubMed ID: 31578771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.
    Sebastianelli A; Spatafora P; Morselli S; Vignozzi L; Serni S; McVary KT; Kaplan S; Gravas S; Chapple C; Gacci M
    Curr Urol Rep; 2020 Oct; 21(12):56. PubMed ID: 33108544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome.
    Sebastianelli A; Morselli S; Spatafora P; Liaci A; Gemma L; Zaccaro C; Vignozzi L; Maggi M; McVary KT; Kaplan SA; Chapple C; Gravas S; Serni S; Gacci M
    Minerva Urol Nephrol; 2021 Dec; 73(6):836-844. PubMed ID: 33200905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study.
    Bechara A; Casabe A; Rodriguez Baigorri G; Cobreros C
    J Sex Med; 2014 Feb; 11(2):498-505. PubMed ID: 24224728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
    Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
    J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial.
    Karami H; Hassanzadeh-Hadad A; Fallah-Karkan M
    Urol J; 2016 Dec; 13(6):2920-2926. PubMed ID: 27928815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction.
    Zhou Z; Zheng X; Wu J; Gao Z; Xu Z; Cui Y
    Am J Mens Health; 2019; 13(5):1557988319882597. PubMed ID: 31625449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.
    Bechara A; Romano S; Casabé A; Haime S; Dedola P; Hernández C; Rey H
    J Sex Med; 2008 Sep; 5(9):2170-8. PubMed ID: 18638006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
    Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
    Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamsulosin and placebo vs tamsulosin and tadalafil in male lower urinary tract symptoms: a double-blinded, randomised controlled trial.
    Nagasubramanian S; John NT; Antonisamy B; Mukha RP; Jeyachandra Berry CS; Kumar S; Devasia A; Kekre NS
    BJU Int; 2020 May; 125(5):718-724. PubMed ID: 32012409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.